China Pharmaceuticals (CRRWF) 8-K Changes in Registrant's Certifying Accountant

Exhibit 16.1

ACSB
	Acquavella, Chiarelli, Shuster, Berkower & Co., LLP
517 Route One	C e r t i f i e d  P u b l i c  A c c o u n t a n t s  a n d  A d v i s o r s	330  7th Avenue
Iselin, New Jersey 08830		Suite 202
732. 855.9600		New York, NY  10001
Fax:732.855.9559		212.867.1319
www.acsbco.com

September 12, 2011

Securities and Exchange Commission

100 F Street NE

Washington D.C. 20549-7561

Re: China Pharmaceuticals, Inc.; Commission File Number 000-52763

Dear Sirs/Madams:

We have read Item 4.01 of the Current Report on Form 8-K to be files by China Pharmaceuticals, Inc. on September 12, 2011 regarding our resignation, and have the following comments:

1.   We agree with the statements made as they pertain to our firm.

2.   We have no basis on which to agree or disagree with any other statements made in Item 4.01.

Yours truly,

/s/ Acquavella, Chiarelli, Shuster, Berkower & Co., LLP

Acquavella, Chiarelli, Shuster, Berkower & Co., LLP

New York, NY

New York ●     New Jersey ●    San Francisco ●    Los Angeles ●    Cayman Islands